1. Home
  2. FRSH vs SUPN Comparison

FRSH vs SUPN Comparison

Compare FRSH & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$7.28

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.34

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
SUPN
Founded
2010
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
FRSH
SUPN
Price
$7.28
$51.34
Analyst Decision
Buy
Strong Buy
Analyst Count
17
5
Target Price
$17.75
$61.60
AVG Volume (30 Days)
5.6M
716.0K
Earning Date
02-10-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$838,809,000.00
$681,539,000.00
Revenue This Year
$14.95
$8.18
Revenue Next Year
$13.98
$22.15
P/E Ratio
$13.86
N/A
Revenue Growth
16.43
4.54
52 Week Low
$8.45
$29.16
52 Week High
$18.78
$57.65

Technical Indicators

Market Signals
Indicator
FRSH
SUPN
Relative Strength Index (RSI) 18.21 59.28
Support Level $8.45 $47.29
Resistance Level $9.14 $51.99
Average True Range (ATR) 0.55 1.45
MACD -0.31 0.23
Stochastic Oscillator 3.61 81.81

Price Performance

Historical Comparison
FRSH
SUPN

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: